Who has invested in Fay?

General Catalyst, Goldman Sachs, Forerunner are named among the investors backing Fay.

Fay Funding: $75M Raised, Series B

Fay funding overview

Fay is a Healthtech company. Fay has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B. Investors on record include General Catalyst, Goldman Sachs, Forerunner. 3 distinct backers are named across the disclosed rounds.

Fay at a glance

Total raised: $75M
Latest round: Series B
Industry: Healthtech
Notable investors: General Catalyst, Goldman Sachs, Forerunner

Frequently asked about Fay funding

How much has Fay raised?: Fay has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Fay?: General Catalyst, Goldman Sachs, Forerunner are named among the investors backing Fay.
What was the latest Fay funding round?: The most recent disclosed round is a Series B.
Where is Fay based?: No headquarters location is disclosed for Fay.
What sector does Fay operate in?: Fay is tracked under Healthtech, with $75M in disclosed funding.

We update the Fay record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies and their backers are listed below.

Fay Funding: $75M Raised, Series B

Fay funding overview

Fay at a glance

Frequently asked about Fay funding

Companies related to Fay (35)

Browse related funding lists (4)